2000-2004 湖南中医药大学，中药学学士

2004-2009 中国药科大学，生药学博士，导师：李萍教授

2009-2010 美国芝加哥大学，生物学博士后，导师：Yuan Chun-Su 2010-今中国药科大学，中药学院，副教授、教授

1. Wei T-T#, Zhang L#*, Li Y#, Li J, Fan Y, Liu J-F, Chen Q-Q, Wang S-L, Li H-L, Alolga RN., Liu B-L, Zhu W*, Li P*, Qi L-W*. Functional Metabolomics Characterizes a Key Role for N-Acetyl-neuraminic Acid in Coronary Artery Diseases.Circulation, Accepted.

2. Fan Y#, Li Y#, Chen Y#, Zhao Y-J, Liu L-W, Li J, Wang S-L, Raphael N. Alolga, Yin Y, Wang X-M, Zhao D-S, Shen J-H, Meng F-Q, Zhou X, Xu H, He G-P, Lai M-D, Li P*, Zhu W*, Qi L-W*. Comprehensive metabolomic characterization of coronary artery diseases. Journal of the American College of Cardiology, 2016; 68(12):1281-1293.

3. Liu Q#, Zhang F-G#, Zhang W-S, Pan A, Yang Y-L, Liu J-F, Li P, Liu B-L, Qi L-W*. Ginsenoside Rg1 inhibits glucagon-induced hepatic gluconeogenesis through Akt-FoxO1 interaction. Theranostics, 20177(16): 4001-4012.

4. Yang Y-L, Li J, Liu K, Zhang L, Liu Q, Liu B-L, Qi L-W*. Ginsenoside Rg5 increases cardiomyocyte resistance to ischemic injury through regulation of mitochondrial hexokinase-II and dynamin-related protein 1. Cell Death & Disease, 2017; 8(2):e2625.

5. Li J, Yang Y-L, Li L-Z, Zhang L, Liu Q, Liu K, Li P, Liu B-L, Qi L-W*. Succinate accumulation impairs cardiac pyruvate dehydrogenase activity through GRP91-dependent and independent signaling pathways: therapeutic effects of ginsenoside Rb1. Biochimica et Biophysica Acta-Molecular Basis of Disease, 2017; 1863(11):2835-2847.

获授权发明专利5项（第一发明人）。